2025-11-11T13:46:30-06:00 2024-12-31 991856619 GRANT THORNTON ADVISORS LLC 53 STATE STREET SUITE 1600 BOSTON MA 02109 990 2024-01-01 350991629 VERSITI INDIANA INC VERS 3179165010 3450 NORTH MERIDIAN STREET INDIANAPOLIS IN 46208 CHRIS MISKEL PRESIDENT & CEO 4149335000 2025-11-11 1 0 ERIN COUTURE P01390592 6177237900 2024 2025-03-06 01:10:19Z CHRIS MISKEL 638 N 18TH STREET MILWAUKEE WI 532332121 104993346 0 X WWW.VERSITI.ORG X 1952 IN (SEE SCHEDULE O) 18 17 877 135 0 0 15903 6849 85136503 93106185 1661373 323568 196849 244671 87010628 93681273 45483 26512 0 0 33429479 36814857 0 0 0 55206257 56727575 88681219 93568944 -1670591 112329 45922381 59403654 11247916 24060391 34674465 35343263 X (SEE SCHEDULE O) 0 0 58818381 26512 66994906 VERSITI INDIANA RECRUITS VOLUNTEER BLOOD DONORS AND COLLECTS, PROCESSES, AND DISTRIBUTES BLOOD PRODUCTS AS PART OF ITS MISSION TO PROVIDE A SAFE AND RELIABLE BLOOD SUPPLY FOR HOSPITALS AND HEALTHCARE SYSTEMS ACROSS INDIANA AND OHIO. IN 2024, VERSITI INDIANA COLLECTED TOTAL RED BLOOD CELLS AND PLATELETS OF 141,860, SERVING 65 HOSPITALS THROUGH 3,978 COMMUNITY BLOOD DRIVES THAT ENGAGED 55,702 VOLUNTEER DONORS. INNOVATION: VERSITI INDIANA PARTNERED WITH THE CRAWFORDSVILLE FIRE DEPARTMENT AND HENRY COUNTY EMS TO PROVIDE PREHOSPITAL WHOLE BLOOD TRANSFUSIONS FOR CRITICALLY INJURED TRAUMA PATIENTS, IMPROVING (CONTINUED IN SCHEDULE O) SURVIVAL RATES BY ENABLING RAPID FIELD TRANSFUSIONS. VERSITI INDIANA ALSO PARTICIPATED IN THE WE GIVE BLOOD DRIVE WITH ABBOTT AND THE BIG TEN CONFERENCE. COMMUNITY OUTREACH: VERSITI INDIANA ENGAGED COMMUNITIES THROUGH LIFELINE @ BUTLER, SIGMA GAMMA RHO SORORITY PARTNERSHIP, INDIANA BLACK EXPO SUPPORT, CIRCLE CITY CLASSIC RADIO INITIATIVES, AND THE #KNOWSCD SICKLE CELL DISEASE AWARENESS CAMPAIGN. DIAGNOSTIC TESTING: VERSITI INDIANA PROVIDES DIAGNOSTIC TESTING SERVICES INCLUDING HEMATOLOGY, COAGULATION, AND MOLECULAR DIAGNOSTICS, CONDUCTING 35,345 TESTS IN 2024. MSI: THE MEDICAL SERVICES INSTITUTE PERFORMED 8 THERAPEUTIC PROCEDURES AND OPERATES CLINICAL RESEARCH PROGRAMS TO ADVANCE PATIENT CARE. THROUGH DEDICATED VOLUNTEER DONORS AND STRATEGIC PARTNERSHIPS, VERSITI INDIANA MAINTAINS A ROBUST BLOOD SUPPLY ENABLING HOSPITALS TO PROVIDE CRITICAL CARE AND LIFESAVING TREATMENTS THROUGHOUT THE REGION. 21845322 26111279 THE VERSITI DONOR TESTING LABORATORY (DTL) PROVIDES INFECTIOUS DISEASE TESTING TO DETERMINE DONOR SUITABILITY AND PRODUCT SAFETY FOR ORGANS, TISSUES, HEMATOPOIETIC STEM CELLS, AND CORD BLOOD. THE DTL OFFERS NUCLEIC ACID TESTING, ANTIBODY SCREENING, AND CONFIRMATORY TESTING FOR MANY DIFFERENT DISEASE STATES. IN 2024, THE DTL CONDUCTED 8,321,196 DONOR TESTS, ENSURING THE SAFETY OF ITS DONATED BIOLOGICAL PRODUCTS. AS PART OF VERSITI'S MISSION TO MAINTAIN THE SAFEST POSSIBLE BLOOD SUPPLY, DONOR TESTING OPERATIONS CONDUCT MANDATORY SCREENING FOR TRANSFUSION-TRANSMISSIBLE INFECTIONS AS REQUIRED BY FDA REGULATIONS. THE DTL UTILIZES STATE-OF-THE-ART NUCLEIC ACID TESTING (NAT) TECHNOLOGY AND SEROLOGICAL METHODS TO DETECT INFECTIOUS AGENTS. VERSITI'S DTL SUPPORTS BLOOD COLLECTION ACTIVITIES (CONTINUED IN SCHEDULE O) ACROSS VERSITI'S ENTIRE GEOGRAPHIC FOOTPRINT WHILE MAINTAINING RIGOROUS QUALITY STANDARDS AND REGULATORY COMPLIANCE. VERSITI'S DONOR TESTING SERVICES STRENGTHEN THE NATIONAL BLOOD SUPPLY INFRASTRUCTURE. BY ENSURING COMPREHENSIVE DONOR SCREENING, VERSITI PROTECTS PATIENTS WHO DEPEND ON SAFE BLOOD TRANSFUSIONS, STRENGTHENS THE NATIONAL BLOOD SUPPLY, AND SUPPORTS THE BROADER PUBLIC HEALTH MISSION OF MAINTAINING CONFIDENCE IN A HIGH-QUALITY BLOOD SUPPLY. 80663703 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 877 1 0 0 0 0 0 0 0 0 0 0 1 0 X 18 17 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 IN X DAWN HENSE 4149335000 638 N 18TH ST MILWAUKEE WI 532332121 X FRED GEILFUSS CHAIR 1.00 5.00 X X 0 0 0 L ALAN WHALEY VICE CHAIR 1.00 4.00 X X 0 0 0 COREEN DICUS-JOHNSON JD SECRETARY 1.00 4.00 X X 0 0 0 RON MILLER TREASURER 1.00 4.00 X X 0 0 0 NICHOLAS BAUER BOARD MEMBER 1.00 4.00 X 0 0 0 DAVID GINSBURG MD BOARD MEMBER 1.00 4.00 X 0 0 0 CECELIA GORE BOARD MEMBER 1.00 4.00 X 0 0 0 GAIL HANSON BOARD MEMBER 1.00 4.00 X 0 0 0 THOMAS HAUSKE JR BOARD MEMBER 1.00 4.00 X 0 0 0 SHERRY HUSA BOARD MEMBER 1.00 4.00 X 0 0 0 DALE KENT BOARD MEMBER 1.00 4.00 X 0 0 0 ROBERT H MANEGOLD BOARD MEMBER 1.00 5.00 X 0 0 0 JEFFREY S MCDONALD BOARD MEMBER 1.00 4.00 X 0 0 0 MAGGEY OPLINGER BOARD MEMBER 1.00 4.00 X 0 0 0 JOHN PERRAS BOARD MEMBER 1.00 4.00 X 0 0 0 KATHY THORNTON-BIAS BOARD MEMBER - THRU 6/24 1.00 4.00 X 0 0 0 GREG WESLEY BOARD MEMBER 1.00 4.00 X 0 0 0 PETER ZIEGLER BOARD MEMBER 1.00 4.00 X 0 0 0 CHRIS MISKEL PRESIDENT & CEO 10.00 45.00 X X 308294 1314302 57669 MICHAEL DEININGER MD EVP & CHIEF SCIENTIFIC OFFICER 1.00 54.00 X 0 670610 39231 MATTHEW ANDERSON MD EVP & CHIEF MED. OFF. - AS OF 7/24 1.00 54.00 X 0 471868 65850 LYNNE BRIGGS VP & CHIEF INFORMATION OFFICER 10.00 45.00 X 91555 390311 52622 JESSICA DROUILLARD VP & CHIEF QUALITY OFFICER 10.00 45.00 X 52447 223590 18905 JAMES WEIDNER EVP & CHIEF HR OFFICER 10.00 45.00 X 108605 462997 56792 GRETCHEN JAMESON EVP & CHIEF MKTG. OFF. - AS OF 4/24 10.00 45.00 X 41879 178536 15013 GITESH DUBAL EVP & CHIEF MKTG. OFF. - THRU 4/24 10.00 45.00 X 77341 329719 23781 DEREK TYUS EVP & CHIEF FINANCIAL OFF. - AS 3/24 10.00 45.00 X 85939 366365 48353 DAN WAXMAN MD VP TRANSFUSION MEDICINE 10.00 45.00 X 83730 356950 51262 BRIAN BAUTISTA EVP & CHIEF OPERATING OFFICER 10.00 45.00 X 154426 658339 53592 BRADLEY PIETZ EVP & CHIEF LABORATORY OFFICER 10.00 45.00 X 114176 486739 65430 BART REUTER EVP & GENERAL COUNSEL 10.00 45.00 X 163705 697895 66046 BARBARA BRYANT EVP & CHIEF MED. OFF. - THRU 8/24 1.00 54.00 X 0 447822 25848 ANTHONY WATKINS EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24 10.00 45.00 X 142255 606456 29876 PENNY SCHROEDER AVP & SR DR DONOR TESTING LABS 55.00 0.00 X 233482 0 15521 MATT COOPER SR MGR DIGITAL MARKETING 55.00 0.00 X 133370 0 49919 LORA POORE SR STRATEGIST INNOVATION 55.00 0.00 X 275713 0 47660 JULIE CRUZ MD SR MEDICAL DIRECTOR 55.00 0.00 X 376721 0 36758 JEFFREY FULLER SR DR ENTERPRISE ARCHITECTURE 55.00 0.00 X 163871 0 40760 2607509 7662499 860888 35 0 1 0 ACTALENT SCIENTIFIC LLC 8415 ALLISON POINTE BLVD 600 INDIANAPOLIS IN 46250 EMPLOYMENT AGENCY 546711 INVITA HEALTHCARE TECHNOLOGIES 135 2ND AVE NORTH JACKSONVILLE FL 32250 SOFTWARE SUPPORT 341777 GPI USA INC 2200 POST OAK BLVD STE 1000 HOUSTON TX 77056 SOFTWARE SUPPORT 322373 KEEN SECURITY AND INVESTIGATIVE SERVICES 1102 SELKIRK LANE INDIANAPOLIS IN 46260 SECURITY SERVICES 263520 CREATIVE TESTING SOLUTIONS 2424 W ERIE DRIVE TEMPE AZ 85282 TESTING SERVICES 226903 14 309 6540 6849 BLOOD SERVICES 621991 61475829 61475829 DONOR TESTING LABORATO 621500 26111279 26111279 DIAGNOSTIC LABORATORIE 621500 5188246 5188246 MEDICAL SERVICES 621500 330831 330831 93106185 351088 351088 11209592 74961 11287948 24125 -78356 50836 -27520 -27520 AFFILIATE SERVICE FEES 900099 238096 238096 CREDIT CARD REBATES 900099 6575 6575 244671 93681273 93106185 0 568239 16512 16512 10000 10000 1482371 384686 1097685 44460 44460 27064400 24343141 2721259 1450723 1273573 177150 4774638 4124441 650197 1998265 1714853 283412 244475 236275 8200 2169 2169 2406385 2162500 243885 631248 54314 576934 412360 376907 35453 948900 685955 262945 2484214 1318597 1165617 1532956 1397499 135457 79461 49363 30098 54173 42800 11373 2495209 1783320 711889 28538 28538 MEDICAL LAB SUPPLIES 28411123 28339448 71675 COST OF IMPORTED PROD 8712331 8712331 VERSITI SERVICES ALLOC 6212535 1875953 4336582 EQUIPMENT LEASE & MAINT 1243391 1061229 182162 828107 700006 128101 93568944 80663703 12905241 0 0 0 0 0 0 159805 17130849 21363236 0 0 0 0 0 0 2938991 3635124 197940 357818 47014965 31749181 13916733 15265784 10552707 4489294 0 0 0 11911345 1185161 2221248 45922381 59403654 8857877 20596551 0 0 0 0 0 0 0 0 0 0 0 0 0 2390039 3463840 11247916 24060391 X 34406654 35075452 267811 267811 34674465 35343263 45922381 59403654 X 112329 558080 -1611 X 0 1 X 1 0 X 117530 95232 15423 15903 6849 250937 85920324 90410211 80959735 85136503 93106185 435532958 86037854 90505443 80975158 85152406 93113034 435783895 0 52422716 4628286 5661269 1989102 810411 65511784 52422716 4628286 5661269 1989102 810411 65511784 370272111 470237 513241 386201 598492 351088 2319259 470237 513241 386201 598492 351088 2319259 92393 5094 196849 244671 539007 86600484 91023778 81361359 85947747 93708793 438642161 0.84410 0.73660 0.00530 0.00600 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: PATRONAGE DIVIDENDS - 2020 AMOUNT: $ 92,386. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 0. MISCELLANEOUS INCOME - 2020 AMOUNT: $ 7. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 0. CREDIT CARD REBATES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 5,094. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 6,575. AFFILIATE SERVICE FEES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 196,849. 2024 AMOUNT: $ 238,096. 60355 60355 60355 60355 60355 60355 60355 60355 60355 60355 1.00000 0 0 1345786 1345786 19301056 16248215 3052841 1572031 1170504 401527 16958758 11215432 5743326 7837334 3115030 4722304 15265784 LEASE LIABILITY 3190420 LONG TERM RETIREMENT LIABILITIES 273420 3463840 X 94186348 558080 558080 93628268 2169 50836 53005 93681273 93517550 -49225 -49225 93566775 2169 2169 93568944 PART V, LINE 4: ENDOWMENTS THE INTENDED USE OF THE ORGANIZATION'S ENDOWMENT FUNDS IS TO PERPETUATE THE MISSION OF VERSITI INDIANA, INC. ADDITIONALLY, THE FILING ORGANIZATION IS A BENEFICIARY OF THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION'S ("VBRIF") ENDOWMENT AS A SUPPORTED ORGANIZATION. THE VBRIF BOARD DESIGNATED ENDOWMENT FUNDS ARE DESIGNATED BY THE BOARD AS ENDOWMENT FUNDS TO ENSURE THE CONTINUING AVAILABILITY OF FUNDS FOR RESEARCH PURPOSES. THE AMOUNT OF THE VBRIF TOTAL ENDOWMENT AS OF 12/31/2024 WAS $113,515,359 AND WAS ALL BOARD RESTRICTED. PART X, LINE 2: INCOME TAXES VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION HAVE ALL RECEIVED TAX DETERMINATION LETTERS CONFIRMING THAT THE ORGANIZATIONS QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). THE ORGANIZATION FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION ARE EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH THEY ARE SUBJECT TO TAX ON INCOME UNRELATED TO THEIR EXEMPT PURPOSES, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE IRC. THE ORGANIZATION HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT HAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. THE ORGANIZATION FILES FEDERAL AND STATE INCOME TAX RETURNS TO REPORT UNRELATED BUSINESS INCOME WHERE APPLICABLE, AND WITH FEW EXCEPTIONS, THOSE PERIODS GENERALLY REMAIN OPEN THREE YEARS FOR FEDERAL PURPOSES AND FOUR YEARS FOR STATE PURPOSES. THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR ANY YEARS WHERE RETURNS WERE NOT FILED. THE ORGANIZATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. THE ORGANIZATION RECOGNIZES, IF NECESSARY, INTEREST AND PENALTIES RELATED TO UNRECOGNIZED TAX BENEFITS IN THE PROVISION FOR INCOME TAXES. THERE WERE NO MATERIAL INTEREST OR PENALTIES RELATED TO INCOME TAXES THAT HAVE BEEN ACCRUED OR RECOGNIZED AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. PART XI, LINE 4B - OTHER ADJUSTMENTS: GAIN ON DISPOSITION OF FIXED ASSETS 18,875. LOSS ON FINANCE LEASES 15,514. GAIN ON OPERATING LEASES 16,447. PART XII, LINE 2D - OTHER ADJUSTMENTS: GAIN ON DISPOSITION OF FIXED ASSETS -18,875. LOSS ON FINANCE LEASES -15,514. GAIN ON OPERATING LEASES -16,447. BAD DEBT RESERVE ADJUSTMENT 1,611. 1 SCHOLARSHIPS 4 10000 PART I, LINE 2: PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. FROM TIME TO TIME, VERSITI INDIANA PROVIDES GRANT ASSISTANCE TO VERSITI WISCONSIN, INC. AND OTHER ORGANIZATIONS. THESE FUNDS WILL SUPPORT FUTURE BLOOD RESEARCH AND OTHER INITIATIVES TO SERVE MORE PATIENTS AND REDUCE OVERALL COSTS. MONITORING THE INVESTMENT OF THESE FUNDS, THE DISTRIBUTIONS AND WHAT THESE FUNDS ARE USED FOR IS COMPLETED BY THE LEADERSHIP OF VERSITI. ADDITIONALLY, THE FILING ORGANIZATION OFFERS SCHOLARSHIPS TO EMPLOYEES AND COMMUNITY MEMBERS IF CERTAIN CRITERIA ARE MET. THE SCHOLARSHIPS ARE SENT TO THE COLLEGE OR UNIVERSITY WHERE THE STUDENT IS ENROLLED. X X X X X 0 0 0 1 1 1 1 1 0 CHRIS MISKEL PRESIDENT & CEO 151449 645649 152134 648570 4711 20083 4589 19562 6369 27149 319252 1361013 0 0 BART REUTER EVP & GENERAL COUNSEL 81804 348741 77028 328382 4873 20772 4589 19562 7960 33935 176254 751392 0 0 BRIAN BAUTISTA EVP & CHIEF OPERATING OFFICER 88494 377263 61776 263360 4156 17716 3490 14876 6693 28533 164609 701748 0 0 ANTHONY WATKINS EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24 62184 265098 67355 287145 12716 54213 4589 19562 1089 4636 147933 630654 0 0 MICHAEL DEININGER MD EVP & CHIEF SCIENTIFIC OFFICER 0 523564 0 118100 0 28946 0 15884 0 23347 0 709841 0 0 BRADLEY PIETZ EVP & CHIEF LABORATORY OFFICER 58409 249001 50869 216861 4898 20877 4551 19400 7881 33598 126608 539737 0 0 JAMES WEIDNER EVP & CHIEF HR OFFICER 60541 258094 43249 184378 4815 20525 4589 19562 6202 26439 119396 508998 0 0 MATTHEW ANDERSON MD EVP & CHIEF MED. OFF. - AS OF 7/24 0 403926 0 65100 0 2842 0 24150 0 41700 0 537718 0 0 LYNNE BRIGGS VP & CHIEF INFORMATION OFFICER 60964 259899 29261 124745 1330 5667 5007 21346 4991 21278 101553 432935 0 0 DEREK TYUS EVP & CHIEF FINANCIAL OFF. - AS 3/24 62558 266689 22800 97200 581 2476 4502 19191 4685 19975 95126 405531 0 0 DAN WAXMAN MD VP TRANSFUSION MEDICINE 70102 298855 10013 42687 3615 15408 4526 19294 5213 22229 93469 398473 0 0 BARBARA BRYANT EVP & CHIEF MED. OFF. - THRU 8/24 0 328620 0 101700 0 17502 0 23946 0 1902 0 473670 0 0 GITESH DUBAL EVP & CHIEF MKTG. OFF. - THRU 4/24 24464 104294 49087 209267 3790 16158 2009 8562 2510 10700 81860 348981 0 0 JULIE CRUZ MD SR MEDICAL DIRECTOR 354419 0 18500 0 3802 0 21370 0 15388 0 413479 0 0 0 LORA POORE SR STRATEGIST INNOVATION 230833 0 41000 0 3880 0 16937 0 30723 0 323373 0 0 0 JESSICA DROUILLARD VP & CHIEF QUALITY OFFICER 37485 159804 10526 44874 4436 18912 2926 12474 666 2839 56039 238903 0 0 PENNY SCHROEDER AVP & SR DR DONOR TESTING LABS 195295 0 33200 0 4987 0 13867 0 1654 0 249003 0 0 0 GRETCHEN JAMESON EVP & CHIEF MKTG. OFF. - AS OF 4/24 41654 177578 0 0 225 958 2609 11122 244 1038 44732 190696 0 0 JEFFREY FULLER SR DR ENTERPRISE ARCHITECTURE 156688 0 5250 0 1933 0 11671 0 29089 0 204631 0 0 0 MATT COOPER SR MGR DIGITAL MARKETING 132542 0 250 0 578 0 10022 0 39897 0 183289 0 0 0 PART I, LINE 3 TOP MANAGEMENT'S COMPENSATION THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR AN INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE VERSITI BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND THE OVERALL DUE DILIGENCE PROCESS. VERSITI INDIANA HAS INCENTIVE PROGRAMS FOR THE CHIEF EXECUTIVE OFFICER AND OTHER CORPORATE OFFICERS DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -OTHER CORPORATE OFFICERS - THE BOARD OF DIRECTORS HAS DELAGATED TO THE CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. CORPORATE OFFICERS ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET PART I, LINES 5A, 5B, 6A, 6B AND 7: NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION; THE INCENTIVE PAYOUT IS DETRMINED; IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL. FORM 990, PART I, LINE 1 VERSITI INDIANA, INC. (VERSITI INDIANA) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE. FORM 990, PART III, LINE 1 STEWARDS OF INDIANA'S BLOOD SUPPLY, LINKING VOLUNTEER DONORS TO HOOSIER PATIENTS IN NEED BY RECRUITING, COLLECTING, PROCESSING, TESTING, LABELING AND DISTRIBUTING BLOOD TO HOSPITALS EVERY DAY. A COMMUNITY BLOOD PROGRAM, SUPPLYING FIRST IN INDIANA THEN WHEREVER THE LIFE-SAVING RESOURCE IS NEEDED. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS OR STOCKHOLDERS VERSITI, INC. (A 501(C)(3) ORGANIZATION) IS THE SOLE CORPORATE MEMBER. FORM 990, PART VI, SECTION A, LINE 7A MEMBER OR STOCKHOLDER POWERS VERSITI, INC. HAS RESERVE POWERS; INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B REFER TO NARRATIVE LISTED IN LINE 7A. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW VERSITI INDIANA UTILIZES GRANT THORNTON TO COMPLETE THR IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE ORGANIZATION'S MANAGEMENT. THE DRAFT FORMS ARE THEN REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE PRIOR TO SUBMISSION TO THE IRS. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY VERSITI INDIANA MAINTAINS A WRITTEN CONFLICT OF INTEREST POLICY. ON AN ANNUAL BASIS, CURRENT DIRECTORS AND OFFICERS ARE ASKED TO COMPLETE A DISCLOSURE FORM BASED ON IRS REQUIREMENTS THAT INCLUDES THE FOLLOWING: WHETHER THEY HAVE ANY DIRECT OR INDIRECT RELATIONSHIP EITHER THROUGH BUSINESS OR FAMILY MEMBER WITH THE ORGANIZATION. WHETHER THEY RECEIVED COMPENSATION FROM ANY ORGANIZATION THAT SHARES COMMON OWNERSHIP OR CONTROL WITH THE ORGANIZATION. WHETHER THEY HAVE SERVED AS AN OFFICER, DIRECTOR, KEY EMPLOYEE, PARTNER OR MEMBER OF AN ENTITY (OR SHAREHOLDER OF A PROFESSIONAL CORPORATION) DOING BUSINESS WITH THE ORGANIZATION. THESE ANSWERS ARE ACCUMULATED, SUMMARIZED AND EVALUATED BY MANAGEMENT TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE WRITTEN POLICY. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION PROCESS THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. FORM 990, PART VI, SECTION C, LINE 19 ORGANIZATION'S DOCUMENTS OPEN TO THE PUBLIC THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST DURING NORMAL BUSINESS HOURS AND AT THE ORGANIZATION'S LOCATION. PART VII: AVERAGE HOURS THE HOURS LISTED ON FORM 990, PART VII ARE REPRESENTATIVE OF AN AVERAGE FOR THE OFFICERS AND EXECUTIVE TEAM. EACH INDIVIDUAL PERSON'S WEEKLY TALLY MAY BE GREATER OR LESSER PER WEEK BASED ON THEIR INDIVIDUAL ROLES AND RESPONSIBILITIES WITHIN THE FILING ORGANIZATION AND RELATED PARTIES. FORM 990, PART XI, LINE 9: BAD DEBT RESERVE ADJUSTMENT -1,611. VERSITI INC PO BOX 2178 638 N 18TH ST MILWAUKEE WI 53201 454675354 SUPPORTING WI 501(C)(3) LINE 12B, II N/A 0 VERSITI WISCONSIN INC PO BOX 2178 638 N 18TH ST MILWAUKEE WI 53201 390807235 BLOOD WI 501(C)(3) LINE 7 VERSITI 0 VERSITI MICHIGAN INC 1036 FULLER AVE NE GRAND RAPIDS MI 49503 381550001 BLOOD MI 501(C)(3) LINE 10 VERSITI 0 VERSITI BLOOD RESEARCH INSTITUTE FNDN PO BOX 2178 638 N 18TH ST MILWAUKEE WI 53201 391372542 SUPPORTING WI 501(C)(3) LINE 12B, II VERSITI 0 VERSITI ILLINOIS INC 1200 N HIGHLAND AVE AURORA IL 60506 362179768 BLOOD IL 501(C)(3) LINE 10 VERSITI 0 CENETRON DIAGNOSTICS LLC 2111 W BRAKER LANE SUITE 300 AUSTIN TX 78758 742760677 LABS & TRIALS TX N/A C 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 0 0